Lancet 2002;359:824-830
Many encounter hurdles associated with prescription rules, insurance rules, and out-of-pocket costs
Products are independently tested by a third-party laboratory, with Certificates of Analysis (COA) available for verified batches
Common adverse effects include nausea, vomiting, diarrhoea, constipation, and abdominal pain , particularly during the dose escalation phase (starting at 0.25 mg and gradually increasing to 2.4 mg over several weeks)
30 , 710
BACKGROUND OF THE INVENTION Field of the Invention (Technical Field): The present invention relates to a method and multiple agents for treatment of sexual dysfunction, including male erectile dysfunction, including separate and preferably sequential administration of a melanocortin 3 and/or 4 receptor agonist, such as Ac-Nle-cyc/o(-Asp-His-D-Phe- Arg-Trp-Lys)-OH (PT-141), preferably by one route of administration, such as intranasal (IN), and a type V phosphodiesterase (PDE-5) inhibitor, such as Viagra , a trademark for a brand of sildenafil, preferably by another route of administration, such as oral
